FORA Capital’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-19,726
Closed -$1.35M 553
2025
Q4
$1.35M Sell
19,726
-2,611
-12% -$134K 0.16% 169
2025
Q3
$1.24M Buy
22,337
+19,189
+610% +$1.12M 0.22% 125
2025
Q2
$217K Sell
3,148
-46,525
-94% -$3.16M 0.02% 443
2025
Q1
$3.45M Buy
49,673
+13,917
+39% +$1.15M 0.35% 93
2024
Q4
$3.08M Sell
35,756
-8,834
-20% -$955K 0.35% 88
2024
Q3
$5.31M Buy
+44,590
New +$5.95M 0.62% 43
2023
Q3
Sell
-54,956
Closed -$4.45M 550
2023
Q2
$4.45M Buy
54,956
+31,648
+136% +$2.59M 0.63% 45
2023
Q1
$1.85M Buy
23,308
+3,130
+16% +$222K 0.19% 156
2022
Q4
$1.37M Sell
20,178
-7,864
-28% -$461K 0.22% 125
2022
Q3
$1.4M Buy
+28,042
New +$1.5M 0.27% 116
2021
Q4
Sell
-25,126
Closed -$1.21M 414
2021
Q3
$1.21M Buy
+25,126
New +$1.21M 0.3% 97
2020
Q4
Sell
-4,914
Closed -$171K 1072
2020
Q3
$171K Sell
4,914
-5,168
-51% -$172K 0.11% 201
2020
Q2
$330K Sell
10,082
-41,530
-80% -$1.33M 0.11% 232
2020
Q1
$1.55M Buy
51,612
+6,146
+14% +$183K 0.34% 67
2019
Q4
$1.32M Buy
+45,466
New +$1.26M 0.13% 205

Other funds holding NVO

FORA Capital's NVO Position: Q1 2026 in Review

FORA Capital sold out of Novo Nordisk (NVO) in Q1 2026, closing a stake of 19,726 shares — an estimated $1.35M sold.

FORA Capital first reported a position in NVO in Q4 2019 and held it in 15 quarters. The position peaked at $5.31M in Q3 2024. 1,271 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • FORA Capital reported no remaining Novo Nordisk position as of Q1 2026 after selling out during the quarter.
  • FORA Capital sold 19,726 Novo Nordisk shares in Q1 2026, an estimated $1.35M.
  • FORA Capital first reported a position in Novo Nordisk in Q4 2019 and held it in 15 quarters.
  • FORA Capital's Novo Nordisk position peaked at $5.31M in Q3 2024.
  • 1,271 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on FORA Capital's 13F filing for Q1 2026, filed 15 May 2026.